Prevalence of Sexual Dysfunction in Female Outpatients and Personnel at a Colombian Hospital: Correlation with Hormonal Profile
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (5), 1208-1213
- https://doi.org/10.1111/j.1743-6109.2007.00718.x
Abstract
Female sexual dysfunction (FSD) is a multifactorial entity and an underestimated problem with an overall prevalence between 20% and 50%. Prevalence can change according to the diagnostic criteria used, data collection, and others such as psychological and cultural factors. Population studies of FSD are limited, both in Colombia and in other countries. Nevertheless, because of the prevalence found in other studies, FSD can be considered a public health issue that affects the quality of life of women who suffer from it and their partners. To determine the prevalence of FSD and its correlation with the hormonal profile in female outpatients and female staff at San Jose Hospital (Bogotá, Colombia). We performed a cross-sectional study with endocrine measurements. The prevalence of FSD according to the Female Sexual Function Index (FSFI) cutoff points, and androgenic deficiency defined as women with a proportion of free testosterone below 2%. Demographic characteristics, medical history survey, FSFI, and a hormonal profile that included follicle stimulating hormore (FSH), luteinizing hormone (LH), prolactin, estrone, estradiol, sulphate and total dehydroepiandrosterone, androstenedione, sex hormone binding globulin, and total testosterone. Fifty (49.5%; 95% confidence interval [CI]: 39.4-59.6%) out of 101 participants met the criteria for FSD; in those women with sexual activity in the past 4 weeks, the prevalence of FSD was 37.8% (95% CI: 27.3-49.1%). In the hormone evaluation sample, 29 out of 32 women with sexual activity in the past 4 weeks met the criteria for FSD. Our results suggest that there is independence between the FSFI scores and the proportion of free testosterone. Our findings suggest that FSD in our population has a prevalence as high as that previously reported in the literature; however, because of the sample selection criteria, we could not say that our study results may well reflect the prevalence in our general Colombian population.This publication has 15 references indexed in Scilit:
- The Prevalence of Sexual Dysfunction and Potential Risk Factors That May Impair Sexual Function in Malaysian WomenThe Journal of Sexual Medicine, 2007
- Sexual Desire in a Nationally Representative Danish PopulationThe Journal of Sexual Medicine, 2007
- Customs, Culture, and Tradition—What Role Do They Play in a Woman’s Sexuality?The Journal of Sexual Medicine, 2006
- Sexual Activity, Prevalence of Sexual Problems, and Associated Help-Seeking Patterns in Men and Women Aged 40–80 Years in Korea: Data from the Global Study of Sexual Attitudes and Behaviors (GSSAB)The Journal of Sexual Medicine, 2006
- Women's Sexual Concerns: Data Analysis from a Help‐LineThe Journal of Sexual Medicine, 2005
- The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff ScoresJournal of Sex & Marital Therapy, 2005
- Hormonal factors in female sexual dysfunctionCurrent Opinion in Urology, 2002
- Female androgen insufficiency: the princeton consensus statement on definition, classification, and assessmentFertility and Sterility, 2002
- The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual FunctionJournal of Sex & Marital Therapy, 2000
- Sexual Dysfunction in the United StatesJAMA, 1999